|Articles|March 6, 2019
Advarra Acquires Quorum Review IRB and Kinetiq
Advertisement
Advarra, provider of institutional review board (IRB), institutional biosafety committee (IBC), and research quality and compliance consulting services in North America, announced the acquisition of Quorum, one of the central IRBs in the U.S. and Canada. The transaction also includes Quorum’s research and technology consulting division, Kinetiq.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Phase IV Trial Shows Strong Immune Response from Moderna’s Updated Spikevax Against LP.8.1 Variant of COVID-19
2
Subcutaneous Saphnelo Shows Positive Phase III Results in Systemic Lupus Erythematosus
3
ACT Brief: Policy Shifts, FDA Inspections, and Tariffs Pose New Challenges for Clinical Trials
4
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
5